TAMPA, FL / ACCESSWIRE / January 6, 2017 / Trxade Group, Inc. (OTCQB: TRXD), a web-based market platform with over 6,700 registered independent pharmacy customers that enables its customers to quickly source and purchase pharmaceuticals, accessories, and services from a wide range of manufacturers and drug distributors, completed the first phase of a comprehensive restructuring plan designed to refocus the company on its core trading platform.
Today CEO Suren Ajjarapu announced that the Company completed the sale of its wholesale and private label distribution division, held under its wholly-owned subsidiary, Westminster Pharmaceutical, on December 31, 2016. This restructuring also included a number of organizational changes and the reduc…
Read the full article at: http://finance.yahoo.com/news/trxade-group-inc-completes-restructuring-143200826.html